<?xml version="1.0" encoding="UTF-8"?>
<Document>
<TEXT>Growth of IV Equipment Market Projected to Amplify During 2017-2022.

RSS
Growth of IV Equipment Market Projected to Amplify During 2017-2022
<NODE id="142" />Persistence Market Research<NODE id="169" /> has announced the addition of the “<NODE id="205" />IV Equipment Market: Global Industry Analysis and Opportunity Assessment, 2017-2022<NODE id="288" />"<NODE id="289" />report<NODE id="295" /> to <NODE id="299" />their offering<NODE id="313" />.
 
New York, NY -- ( <NODE id="335" />SBWIRE<NODE id="341" /> ) -- 10/20/2017 -- Rising cases of needle stick injuries, the shift in demand towards ambulatory surgical centers and <NODE id="460" />fusion pumps<NODE id="472" />, and a greater number of surgical procedures performed are poised to benefit the IV equipment market. Furthermore, a prevalence of chronic diseases in an ageing population in developed nations are positive signs for the IV equipment market. However, lack of wireless connectivity, regulatory mandates for new product launches and increasing cases of medication errors inhibit the unencumbered growth of the IV equipment market that is anticipated to witness a steady CAGR of 5% from 2017 to 2022.
Request to Download and View Full TOC @ https://www.persistencemarketresearch.com/market-research/iv-equipment-market/toc
The <NODE id="1096" />IV catheter<NODE id="1107" /> segment is the most popular in the IV equipment market and should remain so for the foreseeable future. The <NODE id="1216" />IV catheter<NODE id="1227" /> segment is expected to be worth more than US$ 2.7 billion in 2017 itself and companies are recommended to target this segment with gusto. The <NODE id="1370" />infusion pump<NODE id="1383" /> segment is a close second in the IV equipment market in terms of product type segment and is likely to be the biggest winner in terms of market share. Key stakeholders in the IV equipment market would do well to focus their energy on the Europe <NODE id="1629" />infusion pumps<NODE id="1643" /> market as the region accounts for more than a third of the revenue contribution
The securement device segment and <NODE id="1758" />stopclocks<NODE id="1768" /> &amp; <NODE id="1771" />valve<NODE id="1776" /> segment have single digit revenue share in the IV equipment market. While the <NODE id="1855" />former<NODE id="1861" /> is projected to lose market share, the <NODE id="1901" />latter<NODE id="1907" /> is on track to gain share and companies may seek to take advantage of this. The <NODE id="1988" />stopcock<NODE id="1996" /> &amp; <NODE id="1999" />valves<NODE id="2005" /> segment is estimated to grow with a CAGR of just under 6% from 2017 to 2022. Along with Europe, the <NODE id="2106" />stopcocks<NODE id="2115" /> &amp; <NODE id="2118" />valves<NODE id="2124" /> segment has strong potential in APEJ
Request to View Sample Report @ https://www.persistencemarketresearch.com/samples/19297
The <NODE id="2254" />drip chamber<NODE id="2266" /> and <NODE id="2271" />needleless connector<NODE id="2291" /> segment have a revenue share of less than a tenth in the IV equipment market at the end of 2017. The <NODE id="2393" />needleless connector<NODE id="2413" /> segment is predicted to lose substantial share in the near future while the <NODE id="2490" />drip chamber<NODE id="2502" /> segment should fall slowly. The Europe <NODE id="2542" />drip chamber<NODE id="2554" /> segment is assessed to grow past more than US$ 285 million at the end of the forecast period. The <NODE id="2653" />needleless connector<NODE id="2673" /> segment also has the greatest potential in Europe. Along with Europe, companies could additionally target the North America <NODE id="2798" />needleless connector<NODE id="2818" /> segment
Browse Full <NODE id="2839" />Report<NODE id="2845" /> @ https://www.persistencemarketresearch.com/market-research/iv-equipment-market.asp
Hospitals hold the lion's share in the IV equipment market by end user segment and are forecast to hold steady for the medium to long term. Hospitals are the most-well equipped to deal with any and every patient need pertaining to IV treatment. Europe is the largest region in the hospital segment of the IV equipment market but there is a close competition for the second place between APEJ and North America
The companies profiled in the IV equipment market are <NODE id="3394" />AngioDynamics<NODE id="3407" />, <NODE id="3409" />Moog Inc.<NODE id="3418" />, <NODE id="3420" />Terumo Corporation<NODE id="3438" />, <NODE id="3440" />C. R. Bard<NODE id="3450" />, <NODE id="3452" />ICU Medical<NODE id="3463" />, <NODE id="3465" />Smiths Group<NODE id="3477" />, <NODE id="3479" />Baxter International Inc.<NODE id="3504" />, <NODE id="3506" />Fresenius SE &amp; Co.<NODE id="3524" />, <NODE id="3526" />B. Braun Melsungen AG<NODE id="3547" />, and <NODE id="3553" />Becton, Dickinson and Company<NODE id="3582" />
Buy Full <NODE id="3592" />IV Equipment Market Report<NODE id="3618" /> @ https://www.persistencemarketresearch.com/checkout/19297
Media Relations Contact

</TEXT>
<Meta>
<feature featureName="id" featureValue="http://www.sbwire.com/press-releases/growth-of-iv-equipment-market-projected-to-amplify-during-2017-2022-880122.htm@2017-10-20T19:33:00.000+02:00" />
<feature featureName="uri" featureValue="http://www.sbwire.com/press-releases/growth-of-iv-equipment-market-projected-to-amplify-during-2017-2022-880122.htm" />
<feature featureName="lang" featureValue="en" /></Meta><Entities>
<Entity id="0" startPos="142" endPos="169" type="organization" surface="Persistence Market Research" />
<Entity id="1" startPos="205" endPos="288" type="product" surface="IV Equipment Market: Global Industry Analysis and Opportunity Assessment, 2017-2022" />
<Entity id="2" startPos="289" endPos="295" type="product" surface="report" />
<Entity id="3" startPos="299" endPos="313" type="trigger" surface="their offering" />
<Entity id="4" startPos="335" endPos="341" type="organization" surface="SBWIRE" />
<Entity id="5" startPos="460" endPos="472" type="product" surface="fusion pumps" />
<Entity id="6" startPos="1096" endPos="1107" type="product" surface="IV catheter" />
<Entity id="7" startPos="1216" endPos="1227" type="product" surface="IV catheter" />
<Entity id="8" startPos="1370" endPos="1383" type="product" surface="infusion pump" />
<Entity id="9" startPos="1629" endPos="1643" type="product" surface="infusion pumps" />
<Entity id="10" startPos="1758" endPos="1768" type="product" surface="stopclocks" />
<Entity id="11" startPos="1771" endPos="1776" type="product" surface="valve" />
<Entity id="12" startPos="1855" endPos="1861" type="product" surface="former" />
<Entity id="13" startPos="1901" endPos="1907" type="product" surface="latter" />
<Entity id="14" startPos="1988" endPos="1996" type="product" surface="stopcock" />
<Entity id="15" startPos="1999" endPos="2005" type="product" surface="valves" />
<Entity id="16" startPos="2106" endPos="2115" type="product" surface="stopcocks" />
<Entity id="17" startPos="2118" endPos="2124" type="product" surface="valves" />
<Entity id="18" startPos="2254" endPos="2266" type="product" surface="drip chamber" />
<Entity id="19" startPos="2271" endPos="2291" type="product" surface="needleless connector" />
<Entity id="20" startPos="2393" endPos="2413" type="product" surface="needleless connector" />
<Entity id="21" startPos="2490" endPos="2502" type="product" surface="drip chamber" />
<Entity id="22" startPos="2542" endPos="2554" type="product" surface="drip chamber" />
<Entity id="23" startPos="2653" endPos="2673" type="product" surface="needleless connector" />
<Entity id="24" startPos="2798" endPos="2818" type="product" surface="needleless connector" />
<Entity id="25" startPos="2839" endPos="2845" type="product" surface="Report" />
<Entity id="26" startPos="3394" endPos="3407" type="organization" surface="AngioDynamics" />
<Entity id="27" startPos="3409" endPos="3418" type="organization" surface="Moog Inc." />
<Entity id="28" startPos="3420" endPos="3438" type="organization" surface="Terumo Corporation" />
<Entity id="29" startPos="3440" endPos="3450" type="organization" surface="C. R. Bard" />
<Entity id="30" startPos="3452" endPos="3463" type="organization" surface="ICU Medical" />
<Entity id="31" startPos="3465" endPos="3477" type="organization" surface="Smiths Group" />
<Entity id="32" startPos="3479" endPos="3504" type="organization" surface="Baxter International Inc." />
<Entity id="33" startPos="3506" endPos="3524" type="organization" surface="Fresenius SE &amp; Co." />
<Entity id="34" startPos="3526" endPos="3547" type="organization" surface="B. Braun Melsungen AG" />
<Entity id="35" startPos="3553" endPos="3582" type="organization" surface="Becton, Dickinson and Company" />
<Entity id="36" startPos="3592" endPos="3618" type="product" surface="IV Equipment Market Report" /></Entities><Relations>
<Relation id="37" NAME="company_provides_product">
<Entity id="1" label="product" />
<Entity id="0" label="company" />
<Entity id="3" label="trigger" />
</Relation>
<Relation id="38" NAME="identity">
<Entity id="1" label="source" />
<Entity id="36" label="target" />
<Entity id="25" label="target" />
<Entity id="2" label="target" />
</Relation>
<Relation id="39" NAME="identity">
<Entity id="5" label="source" />
<Entity id="9" label="target" />
<Entity id="8" label="target" />
</Relation>
<Relation id="40" NAME="identity">
<Entity id="6" label="source" />
<Entity id="7" label="target" />
</Relation>
<Relation id="41" NAME="identity">
<Entity id="10" label="source" />
<Entity id="12" label="target" />
<Entity id="14" label="target" />
<Entity id="16" label="target" />
</Relation>
<Relation id="42" NAME="identity">
<Entity id="11" label="source" />
<Entity id="15" label="target" />
<Entity id="13" label="target" />
<Entity id="17" label="target" />
</Relation>
<Relation id="43" NAME="identity">
<Entity id="18" label="source" />
<Entity id="21" label="target" />
<Entity id="22" label="target" />
</Relation>
<Relation id="44" NAME="identity">
<Entity id="19" label="source" />
<Entity id="23" label="target" />
<Entity id="24" label="target" />
<Entity id="20" label="target" />
</Relation></Relations>
</Document>
